-
Shares of Aimmune Therapeutics skyrocketed in extended trading Friday after the U.S. Food and Drug Administration approved the company's drug that reduces kids' allergic reactions to peanuts. More on this -
For more news, please go to FoxBusiness.com and watch Fox Business Network. |
No comments:
Post a Comment